WFC
61
3
SLG
60
4
RIG
5
-2
HP
32
2
PFG
53
8
PCG
50
5
ROK
71
3
AMT
46
4
STT
50
5
FOX
60
-2
JCI
70
2
AON
62
2
WYNN
45
-3
APH
65
7
RHI
27
2
AIV
51
3
EFX
50
3
UNM
53
4
MU
48
-4
AA
53
2
WFC
61
3
SLG
60
4
RIG
5
-2
HP
32
2
PFG
53
8
PCG
50
5
ROK
71
3
AMT
46
4
STT
50
5
FOX
60
-2
JCI
70
2
AON
62
2
WYNN
45
-3
APH
65
7
RHI
27
2
AIV
51
3
EFX
50
3
UNM
53
4
MU
48
-4
AA
53
2
Financhill
Back

Autolus Therapeutics PLC 10K Form

Buy
59

AUTL
Autolus Therapeutics PLC

Last Price:
$2.42
Seasonality Move:
-11.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $10.1M
Cash Flow: $-83.8M
Price / Cash Flow: 0
Annual Sales: $1.39
Price / Book: 1.75

Profitability

EPS (TTM): -0.88000
Net Income (TTM): $-238.1M
Gross Margin: $-1.3M
Return on Equity: -49.92%
Return on Assets: -28.96%

Autolus Therapeutics PLC Earnings Forecast

Key Autolus Therapeutics PLC Financial Ratios

  • The Gross Profit Margin over the past 2 years for AUTL is -12.52%.
  • The Selling, General & Administrative Expenses for AUTL have been equal to 998.87% of Gross Profit Margin.
  • The Research & Development expenses have been 1,367.94% of Revenue.
  • The Net Earning history of AUTL is -2,180.45% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 6 years.

Autolus Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.24
Quick Ratio: 8.74

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Buy
59
Autolus Therapeutics PLC (AUTL) is a Buy

Is Autolus Therapeutics PLC a Buy or a Sell?